ProLabs Launches USDA-Approved LTCI To Aid In Treatment Of FeLV And FIV

Main Category: Veterinary
Article Date: 19 Apr 2009 - 1:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:4 stars

3.78 (9 votes)

Healthcare Prof:3 and a half stars

3.25 (4 votes)

Article Opinions: 1 posts

Veterinarians and Cat Owners Get Help in Treating Killer Diseases. Feline leukemia virus (FeLV) and Feline Immunodeficiency virus (FIV) are the most common life-threatening infectious diseases of cats. Until LTCI's introduction, there was no approved treatment for these widespread, incurable viruses that, like HIV/AIDS in people, suppress the immune system.

About 3% of all US cats are infected with FeLV, and a similar number suffer with FIV. These rates are dramatically higher in stray cats and house cats that go outside.

As news of the availability of LTCI's (Lymphocyte T-Cell Immunomodulator) groundbreaking technology spread, excited cat owners were buzzing about it well before most veterinarians had an opportunity to read about it in their professional journals.

"As soon as we announced the launch of LTCI, concerned pet owners and hopeful veterinarians -- who have been looking for a treatment for FeLV-FIV for decades -- have been calling and e-mailing with questions about how LTCI works and where to get it," reports Brian Reardon, Brand Manager for ProLabs, Ltd., the marketers of LTCI. "It's a great product to talk about: It's safe, and as the only FeLV/FIV treatment that has ever been granted a conditional license by the USDA, ProLabs is in a very enviable position within the pet animal health world."

Until LTCI became available, veterinarians who diagnosed feline patients with FeLV and/or FIV had no approved treatment for these disorders. "LTCI provides veterinarians with an approved treatment option beyond anything previously possible. Telling clients that 'there is nothing to be done' for their cat should no longer be in a practitioner's lexicon when it comes to treating cats with FeLV/FIV," commented ProLabs Technical Services Manager, Dr. Joel Ehrenzweig, at a recent meeting of the American Association of Feline Practitioners.

Source
ProLabs and Tradewinds, divisions of AgriLabs, Ltd.

Article adapted by Medical News Today from original press release.
Visit our veterinary section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
ProLabs and Tradewinds, divisions of AgriLabs, Ltd. "ProLabs Launches USDA-Approved LTCI To Aid In Treatment Of FeLV And FIV." Medical News Today. MediLexicon, Intl., 19 Apr. 2009. Web.
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/146558.php>

APA
ProLabs and Tradewinds, divisions of AgriLabs, Ltd. (2009, April 19). "ProLabs Launches USDA-Approved LTCI To Aid In Treatment Of FeLV And FIV." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/146558.php.

Please note: If no author information is provided, the source is cited instead.


Veterinary

Most Popular Articles



Follow Our Veterinary News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Veterinary Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »